Brief communicationVentricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation
References (12)
- et al.
The historical development, cellular electrophysiology and pharmacology of amiodarone
Prog Cardiovasc Dis
(1989) - et al.
Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation
- et al.
Effect of drugs in the Wolff-Parkinson-White syndrome
- et al.
Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation
Am J Cardiol
(1984) - et al.
Ventricular fibrillation in the Wolff-Parkinson-White syndrome
N Engl J Med
(1979) Proarrhythmia in patients treated for atrial fibrillation or flutter
Ann Intern Med
(1992)
There are more references available in the full text version of this article.
Cited by (48)
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
2020, Canadian Journal of CardiologyEfficacy of amiodarone in a case with pre-excited atrial fibrillation with a precarious conduction property of the accessory pathway
2020, HeartRhythm Case ReportsCitation Excerpt :It is known that the effects of amiodarone in the acute phase enhance the inhibition of inward sodium and calcium currents, whereas voltage- and ligand-gated potassium channel currents are decreased with oral administration in the chronic phase.5 Furthermore, intravenous amiodarone administration may have a more prevalent effect on AV node conduction than on AcP conduction.3 Intravenous amiodarone administration has calcium channel-blocking activity, which has a rate-dependent effect on AV node conduction (the greater the effect, the more rapid the rate, such as AF conduction).6
Nifekalant: A New Option for Pre-Excited Atrial Fibrillation With a High-Risk Accessory Pathway
2020, JACC: Case Reports2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
2016, Journal of the American College of Cardiology
Copyright © 1996 Published by Mosby, Inc.